SEATTLE, April 28, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company specializing in the development of immunotherapeutics and vaccines in the areas of oncology and infectious disease, today announced its Chairman and CEO, Dr. Glynn Wilson, will present at the Aegis Capital Emerging Growth Conference on Saturday, April 30. The conference will take place between April 28 and April 30 at the Palazzo Hotel in Las Vegas.
